Skip to main content

ETF comparison

VHT vs XBI

Both Healthcare.

Vanguard Health Care Index Fund ETF Shares · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
12.9 %

125 positions appear in both funds. Buying equal dollars of VHT and XBI would leave roughly 12.9% of each dollar exposed to the same underlying securities.

VHT unmatched 86.9% Shared 12.9% XBI unmatched 87.0%

Unmatched is the part of a fund's weight the other fund doesn't match: names only it holds, plus any extra weight it puts in names both funds hold.

In VHT only
273 positions
Shared
125 positions
In XBI only
31 positions

Side by side

VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$21.81B
whole fund, 2 share classes
TTM yield
1.39%
Top-10 conc.
51.9%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

82 composite / 100
Expense ratio
0.35%
Net assets
$10.36B
TTM yield
0.36%
Top-10 conc.
13.3%

Sub-score comparison

91
Cost
65
83
Tax efficiency
85
100
Liquidity
100
40
Concentration
95
—
Tracking quality
—
VHT sub-score XBI

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

VHT is 26 bps cheaper than XBI. On a $100,000 position that's about $260/yr more in fees for XBI.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with VHT vs XBI.

Top shared holdings

125 shared in total
# Holding In VHT In XBI Overlap
1 Vertex Pharmaceuticals Inc 1.80% 1.06% 1.06%
2 AbbVie Inc 6.09% 1.04% 1.04%
3 Amgen Inc 2.87% 0.99% 0.99%
4 Gilead Sciences Inc 2.64% 0.96% 0.96%
5 Regeneron Pharmaceuticals Inc 1.00% 0.96% 0.96%
6 Alnylam Pharmaceuticals Inc 0.63% 0.96% 0.63%
7 Natera Inc 0.46% 1.16% 0.46%
8 Biogen Inc 0.45% 1.03% 0.45%
9 REVOLUTION Medicines Inc 0.40% 1.20% 0.40%
10 Insmed Inc 0.36% 1.08% 0.36%
11 United Therapeutics Corp 0.36% 0.92% 0.36%
12 Incyte Corp 0.26% 1.00% 0.26%

Only in VHT

273 total
  • Eli Lilly & Co 14.04%
  • Johnson & Johnson 8.47%
  • UnitedHealth Group Inc 5.45%
  • Merck & Co Inc 4.66%
  • Thermo Fisher Scientific Inc 2.93%
  • Intuitive Surgical Inc 2.38%
  • Pfizer Inc 2.35%
  • Abbott Laboratories 2.35%
  • Bristol-Myers Squibb Co 1.84%
  • Danaher Corp 1.84%

Only in XBI

31 total
  • SELLAS Life Sciences Group Inc 1.19%
  • uniQure NV 1.03%
  • CRISPR Therapeutics AG 1.02%
  • Absci Corp 0.56%
  • Capricor Therapeutics Inc 0.49%
  • Hyperliquid Strategies Inc 0.46%
  • Inhibrx Biosciences Inc 0.35%
  • Avalo Therapeutics Inc 0.35%
  • Jade Biosciences Inc 0.32%
  • Vor BioPharma Inc 0.30%

Percentages are holdings overlap with the named fund.

Open VHT or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.